- Email: [email protected]
Pharmacology & Therapeutics Keyword Index, Volume 100, 2003
Pharmacology & Therapeutics 100 (2003) 309 www.elsevier.com/locate/pharmthera
PHARMACOLOGY & THERAPEUTICS KEYWORD INDEX, VOLUME 100, 2003 Adenosine, 31 Adenosine receptors, 31 Alcoholism, 235 Allergic disease, 157 Allergy, 75 Alzheimer’s disease, 63 Antiarrhythmic drugs, 89 Antibodies, 101 Anticancer therapy, 119 Antigen-presenting cells, 75 Antioxidant action, 215 Antitumor, 1 Antitumor therapy, 31 Antiviral, 1 Antiviral therapy, 119 Ape, 235 Apoptosis, 1, 31, 257 B-1 B-cells, 157 Behavior, 235 h-blockers, 215 Brain, 235 Ca2+calmodulin-dependent protein kinase, 291 Calcineurin, 141 Cardiac allograft, 141 CD14, 171 cDNA microarray, 63 Central nervous system, 291 Chemical inducers, 257 Chemotherapy, 119 Clinical trials, 49 Coronary artery disease, 89 Cyclosporine, 141 Cytokines, 1
Dendritic cells, 75 Deoxyribonucleoside kinase, 119 Dephosphorylation, 291 Differentiation, 1, 257 Disease-modifying drug, 49 Dose response, 49 Endotoxin tolerance, 171 Fluorescence, 101 Fluorescence resonance energy transfer, 101 Free radical trapping agents, 195 Gene expression, 63 Gene segments, 157 Green fluorescent protein, 101 Hematopoietic cells, 257 Imaging, 101 Immune response, 1 Immune tolerance, 75 Immunoglobulin, 157 Immunosuppression, 75, 141 Implantable cardioverter defibrillator, 89 Insulin sensitivity, 215 Interferon-h,49 Leukemia, 257 Lipid metabolism, 215 LPS, 171 Macrophages, 171 MD-2, 171 Mechanisms, 257
0163-7258/$ – see front matter D 2003 Elsevier Inc. All rights reserved. doi:10.1016/S0163-7258(03)00159-1
Monkey, 235 Multiple sclerosis, 49 Negative regulation, 291 Neuroprotection, 195 Neuroscience, 63 Nitric oxide, 215 Nitrones, 195 Nucleoside analogue, 119 NXY-059, 195 PBN, 195 Phosphorylation, 291 Polyreactivity, 157 Proliferation, 31 Protein phosphatase, 291 Proteomics, 63 Randomized prospective clinical trials, 89 Receptors, 101 Reentry, 89 Repertoire, 157 Ribonucleoside kinase, 119 Schizophrenia, 63 Self-administration, 235 Signaling, 1 Stroke, 195 TLR4, 171 Transplant vascular disease, 141 Tumor, 31 Vasodilatation, 215 Ventricular fibrillation, 89
PHARMACOLOGY & THERAPEUTICS KEYWORD INDEX, VOLUME 100, 2003 Adenosine, 31 Adenosine receptors, 31 Alcoholism, 235 Allergic disease, 157 Allergy, 75 Alzheimer’s disease, 63 Antiarrhythmic drugs, 89 Antibodies, 101 Anticancer therapy, 119 Antigen-presenting cells, 75 Antioxidant action, 215 Antitumor, 1 Antitumor therapy, 31 Antiviral, 1 Antiviral therapy, 119 Ape, 235 Apoptosis, 1, 31, 257 B-1 B-cells, 157 Behavior, 235 h-blockers, 215 Brain, 235 Ca2+calmodulin-dependent protein kinase, 291 Calcineurin, 141 Cardiac allograft, 141 CD14, 171 cDNA microarray, 63 Central nervous system, 291 Chemical inducers, 257 Chemotherapy, 119 Clinical trials, 49 Coronary artery disease, 89 Cyclosporine, 141 Cytokines, 1
Dendritic cells, 75 Deoxyribonucleoside kinase, 119 Dephosphorylation, 291 Differentiation, 1, 257 Disease-modifying drug, 49 Dose response, 49 Endotoxin tolerance, 171 Fluorescence, 101 Fluorescence resonance energy transfer, 101 Free radical trapping agents, 195 Gene expression, 63 Gene segments, 157 Green fluorescent protein, 101 Hematopoietic cells, 257 Imaging, 101 Immune response, 1 Immune tolerance, 75 Immunoglobulin, 157 Immunosuppression, 75, 141 Implantable cardioverter defibrillator, 89 Insulin sensitivity, 215 Interferon-h,49 Leukemia, 257 Lipid metabolism, 215 LPS, 171 Macrophages, 171 MD-2, 171 Mechanisms, 257
0163-7258/$ – see front matter D 2003 Elsevier Inc. All rights reserved. doi:10.1016/S0163-7258(03)00159-1
Monkey, 235 Multiple sclerosis, 49 Negative regulation, 291 Neuroprotection, 195 Neuroscience, 63 Nitric oxide, 215 Nitrones, 195 Nucleoside analogue, 119 NXY-059, 195 PBN, 195 Phosphorylation, 291 Polyreactivity, 157 Proliferation, 31 Protein phosphatase, 291 Proteomics, 63 Randomized prospective clinical trials, 89 Receptors, 101 Reentry, 89 Repertoire, 157 Ribonucleoside kinase, 119 Schizophrenia, 63 Self-administration, 235 Signaling, 1 Stroke, 195 TLR4, 171 Transplant vascular disease, 141 Tumor, 31 Vasodilatation, 215 Ventricular fibrillation, 89